Euroz Hartleys Report | 22 June 2022 June 22, 2022/in Featured, Latest News, News /by Haley Chartres Botanix (ASX:BOT) is pleased to share a research report from leading stockbroking firm, Euroz Hartleys, following the acquisition of our dermatology asset Sofpironium Bromide. Click here to view the report. https://botanixpharma.com/wp-content/uploads/Botanix-Euroz.png 321 845 Haley Chartres /wp-content/uploads/botanix-logo.png Haley Chartres2022-06-22 20:34:002023-03-13 21:16:02Euroz Hartleys Report | 22 June 2022
